Scilex Pharmaceuticals, Inc is an innovative revenue-generating company based in San Diego, CA, focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. With a commitment to social, environmental, economic, and ethical principles, Scilex aims to responsibly develop pharmaceutical products to maximize the quality of life.
Scilex's non-opioid pain management portfolio includes ZTlido, indicated for the relief of pain associated with post-herpetic neuralgia in adults; Elyxyb, a prescription nonsteroidal anti-inflammatory drug used for the acute treatment of migraine in adults; and Gloperba, indicated for the prophylaxis of gout flares in adults. Through their dedication to innovation and patient well-being, Scilex Pharmaceuticals strives to become a global leader in pain management.
Generated from the website